5th International Conference on Heart and Cardiovascular Diseases

Heart Failure and Advanced Cardiac Therapies remains an important area in modern cardiovascular medicine due to the growing need for evidence-based diagnosis, advanced therapeutic strategies, precision healthcare, and improved patient outcomes. This session provides a scientific platform for clinicians, researchers, healthcare professionals, and academicians to discuss recent clinical developments, emerging technologies, translational research, and future directions associated with heart failure and advanced cardiac therapies. The session will feature expert presentations, clinical discussions, case-based learning, and interdisciplinary perspectives focused on improving cardiovascular healthcare delivery and advancing global cardiology research.

Key Discussion Areas

• Optimizing and sequencing the four pillars of guideline-directed medical therapy in HFrEF
• How treatment options are evolving for HFpEF as new drug classes emerge
• When to escalate to mechanical circulatory support versus transplant listing
• Remote monitoring and implantable sensors for early decompensation detection
• Managing heart failure with comorbid kidney disease and diabetes
• Navigating palliative and end-of-life care conversations in advanced heart failure

Sub Tracks

• HFrEF and HFpEF Management
• Guideline-Directed Medical Therapy Optimization
• Mechanical Circulatory Support and LVADs
• Heart Transplantation
• Remote Monitoring and Heart Failure Devices
• Advanced and Palliative Heart Failure Care
• Heart Failure Biomarkers
• Cardiac Contractility Modulation

Why Attend This Session?

Heart failure specialists, general cardiologists, cardiac surgeons, and advanced practice providers will gain practical frameworks for phenotype-guided therapy selection, guideline-directed medical therapy titration, and up-to-date knowledge on pivotal trial results reshaping cardiomyopathy management.

Related Topics

Cardiomyopathies & Genetics | Cardiovascular Surgery | Electrophysiology & Arrhythmias | Hypertension & Cardiorenal Medicine | AI & Digital Cardiology

Frequently Asked Questions

Q: Who should attend?

A: Heart failure specialists, transplant cardiologists, and clinicians managing advanced or acute heart failure.

Q: Are mechanical circulatory support devices discussed?

A: Yes, LVAD and other mechanical circulatory support technologies are a dedicated sub-track.

Q: Does this track address remote patient monitoring?

A: Yes, digital and remote monitoring approaches to reduce readmissions are covered.

Q: Is transplantation included in this track?

A: Yes, heart transplantation and advanced therapy pathways are a core discussion area.